VB8-12487-66133
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 331 / FL
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Moderna
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 2 — Moderna
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-05-06
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Diarrhoea, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold symptoms and diarrheaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-18
-
2022-02-02
Survey response — 12 months, dose 2MedDRA: Alpha 1 foetoprotein increased, Thyroid disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Thyroid issues and maternal serum afp elevatedMedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-02-03
- 2022-02-04
-
2022-04-25
Dose 3 — Moderna
- 2022-04-27
-
2022-04-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
-
2022-05-09
Survey response — day 14, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cough and congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-09
Report sent to call center — day 14, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-10
- 2022-05-10
- 2022-05-10
- 2022-05-18
- 2022-05-23
- 2022-05-31
- 2022-06-06
- 2022-07-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2022-04-25 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-05 | Unsuccessful | |
| 2022-02-02 | Unsuccessful | |
| 2022-05-09 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Cold symptoms and diarrhea
Release 11 — 12 months, dose 2
Symptoms: Thyroid issues and maternal serum afp elevated
Release 11 — day 14, dose 3
Symptoms: Cough and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Alpha 1 foetoprotein increased | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Thyroid disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release